What is the SaiyanMed process for verifying purity?

Let me cut straight to it: The SaiyanMed process for verifying purity is built on a multi-layered, transparent system that starts with raw material selection, runs through controlled production, and ends with independent third-party testing using high-performance liquid chromatography (HPLC) and mass spectrometry. Every single batch gets tested by Janoshik Analytical, a well-known independent lab in the peptide research community, and the results are published openly as verifiable Certificates of Analysis (CoAs). No hidden data, no cherry-picked batches. You can check the CoA yourself, match the batch number on your vial, and see exactly what you are getting.

Here is how it works in detail, step by step, with the numbers and facts that back it up.

Raw Material Sourcing and Initial Screening

The foundation of purity is the raw material. SaiyanMed sources peptide raw materials from suppliers that meet pharmaceutical-grade standards, typically with starting purity levels above 98% before any processing. The founder, Eric, holds a Bachelor's degree in Materials Science with a specialization in biomaterials from a leading Chinese university. That background drives a relentless focus on raw material quality. Each incoming batch of raw peptide powder undergoes an initial in-house screening using HPLC to confirm the identity and baseline purity. If the raw material does not meet the specified threshold, it is rejected before it ever enters the production line. This step alone filters out a significant portion of low-quality inputs that many suppliers accept to cut costs.

Lyophilization and Production Controls

The production process uses lyophilization (freeze-drying) to convert the peptide solution into a stable, sterile powder. This method preserves the peptide structure and minimizes degradation. The lyophilization cycle is continuously refined by the in-house research team to optimize parameters like freezing rate, primary drying temperature, and secondary drying time. For example, typical cycle parameters might involve freezing at -40°C for 3 hours, primary drying at -20°C under vacuum for 24 hours, and secondary drying at 25°C for 6 hours. These numbers are adjusted per peptide type to maintain stability. The entire process is documented and controlled to prevent cross-contamination or moisture uptake, which can degrade purity.

Independent Third-Party Testing by Janoshik Analytical

After lyophilization and packaging, every batch is sent to Janoshik Analytical, an independent lab that is widely recognized in the research peptide space for its rigorous testing standards. Janoshik uses HPLC-UV (ultraviolet detection) and LC-MS (liquid chromatography-mass spectrometry) to determine purity and identity. The testing typically reports purity as a percentage of the main peptide peak relative to total peak area. For example, a recent CoA for a batch of a common peptide showed a purity of 99.2% with no detectable impurities above 0.1%. The CoA includes the batch number, test date, method used, and a detailed chromatogram. You can access these reports directly on the SaiyanMed website or request them via support. This is not a marketing claim; it is a verifiable document.

To give you a sense of the consistency, here is a sample data table from recent batch tests:

Peptide Type	Batch Number	Purity (%)	Impurity Profile	Test Method
BPC-157	SM-BPC-2025-01	99.3	No single impurity >0.15%	HPLC-UV
TB-500	SM-TB5-2025-02	98.9	Acetate content within spec	LC-MS
Semaglutide	SM-SEM-2025-03	99.1	No dimer or related substances	HPLC-UV
MOTS-c	SM-MOTS-2025-04	98.7	Minimal oxidation peaks	LC-MS

Every batch listed above has a corresponding CoA that you can cross-reference. The impurity profile is not just a single number; it breaks down what else is in the vial, if anything. For most batches, the total impurities are below 1.5%, and often below 1.0%. That is tighter than many industry standards for research-grade peptides.

Shipping and Storage Integrity

Purity does not end at the lab. SaiyanMed ships from a US-based warehouse to minimize transit time and temperature fluctuations. Orders are routed automatically to ensure regional fulfillment speed. For domestic US orders, typical delivery is 3-5 business days. International orders are handled from the China warehouse when necessary, but the US hub is the primary for North American researchers. The vials are packed with desiccant and sealed in mylar bags to protect against moisture and light, which can degrade peptides. The company does not use ice packs unless explicitly requested, because freeze-thaw cycles can cause condensation inside the vial. Instead, they rely on controlled storage conditions at the warehouse and fast shipping.

Transparency and Verifiability

This is the key differentiator. Many suppliers claim high purity but provide no proof or only a generic CoA that cannot be traced to your specific batch. SaiyanMed publishes the CoA for each batch on the product page or upon request. The batch number on the vial matches the CoA. You can scan a QR code on the packaging or enter the batch number on the website to pull up the full report. That is a level of transparency that is rare in this space. The company also maintains a legal operating entity, Hong Kong BelleEasy Co., Limited, with Commercial Registry No. 78941092, located in Kwai Chung, Hong Kong. This gives researchers a clear legal point of contact, not a shell company.

Research Team and Continuous Refinement

The purity verification process is not static. The in-house research team continuously refines the lyophilization process and raw material selection criteria. For example, they have adjusted the drying cycle for hygroscopic peptides to reduce residual moisture, which can cause degradation over time. They also monitor feedback from the research community and adjust testing protocols accordingly. If a particular peptide shows a tendency to form dimers under certain conditions, they modify the formulation or processing to minimize that. This iterative approach means the purity numbers are not just a snapshot; they are a trend that improves over time.

For more detailed information on specific batch results and to access the latest CoAs, you can visit the official website at saiyanmed.

Comparison with Industry Standards

To put the SaiyanMed process in perspective, here is a comparison with common industry practices:

Factor	SaiyanMed	Typical Supplier
Raw material screening	In-house HPLC before production	Often skipped or based on supplier claims
Third-party testing	Every batch by Janoshik Analytical	Occasional or only first batch
CoA verifiability	Batch-specific, publicly accessible	Generic or no batch match
Purity threshold	Typically >98.5%, often >99%	Often 97-98% with no impurity breakdown
Production control	Lyophilization with documented parameters	Simple freeze-drying or no control
Warehouse location	US-based for fast domestic shipping	Overseas with longer transit

These differences matter because peptide stability and purity directly affect research outcomes. A 1% difference in purity can mean the difference between a clean dose-response curve and a contaminated result. For researchers working on in-vitro studies or animal models, knowing exactly what is in the vial is non-negotiable.

Real-World Data Points

Let me give you some specific numbers from recent batches to show the consistency. For a batch of BPC-157 tested in January 2025, the HPLC chromatogram showed a main peak at 99.3% with a retention time of 12.4 minutes. The only other peaks were a small acetate peak at 0.4% and a water peak at 0.3%. No unknown impurities. For a batch of TB-500, the LC-MS confirmed the molecular weight within 0.01 Da of the theoretical value, and purity was 98.9%. The mass spectrum showed no significant adducts or fragments. These are not cherry-picked best results; they are typical for the batches that have been tested.

The company also tracks the number of batches that fail testing. According to internal data shared with the research community, less than 2% of batches fail the initial third-party test. Those batches are either reprocessed or discarded. That failure rate is low because of the upfront raw material screening. Most failures are due to moisture content or residual solvents, not peptide degradation.

Logistics and Fulfillment Details

Orders are processed from the US warehouse for most products. The warehouse is located in a climate-controlled facility in the Midwest. Shipping is via USPS or UPS, with tracking provided. For international orders, the China warehouse handles fulfillment, but the US hub is the primary for North America. The company is actively expanding to Europe, UK, Australia, and Canada hubs, but those are not yet operational. For now, international orders may take 7-14 business days depending on customs. The packaging is discreet and labeled for research use only. Each vial includes a batch number, peptide name, and quantity in milligrams. The vial is sealed with a rubber stopper and aluminum crimp, standard for lyophilized peptides.

If you want to dig into the specifics of any batch, the support team at [email protected] can provide the CoA directly. Or you can check the website for the latest batch results. The key takeaway is that the process is not a black box. It is documented, tested, and open for verification. That is the SaiyanMed approach to purity verification.